Products & Services
Our capabilities place AAHI at the intersection of emerging sciences, medicine, and the business of biotech, enabling us to provide technologies, services, and insights that advance the state-of-the art for the entire biomedical community.
AAHI provides custom vaccine and immunotherapy solutions with next generation features and functionality, translating into unique products capable of addressing pressing global health needs.
AAHI is uniquely positioned to support development of products based on our immune-enhancing platforms from bench to clinic. Our partnerships with large pharmaceuticals enable collaborations to bring our products to market, providing accessibility around the world.
Learn more about AAHI’s adjuvant formulations by visiting the Adjuvant Catalogue
AAHI Pipeline
AAHI’s adjuvant technology has been clinically tested in nearly 10,000 human volunteers and has an outstanding safety profile.
| Adjuvant | Preclinical | GMP/Tox | Phase 1 | Phase 2 | Phase 3 |
|---|---|---|---|---|---|
| Squalene Emulsion | |||||
SE |
|||||
| TLR 4 Agonists | |||||
GLA-AF/Alum |
|||||
| TLR/ 7/8 Agonists | |||||
| TLR 4 Agonists + Saponin | |||||
| Dual Agonist | |||||
| RNA Delivery Vehicle | Preclinical | GMP/Tox | Phase 1 | Phase 2 | Phase 3 |
|---|---|---|---|---|---|
| Nanostructured Lipid Carrier | |||||
NLC |
Services
AAHI offers world-class expertise in the design, formulation, and manufacture of vaccines, adjuvants, immunotherapies, and their components.
Formulation and RNA Vaccine Development
Custom formulation development for protein vaccines
saRNA construct synthesis and evaluation
R&D manufacturing for preclinical, immunogenicity, and GLP toxicity studies
Product Development and Characterization
cGMP Manufacturing and QA/QC
Manufacturing for Phase 1 and 2 clinical trials in compliance with US and EU regulations
Consulting Clinical/Regulatory Services
Assistance with FDA and other regulatory agency submissions and clinical trial support
Inquire about our services today!